Cell Membrane Molecules on Neoplastic Cells: Their Role in Malignant Cell Transformation and Dissemination
Part of the
NATO ASI Series
book series (NSSA, volume 113)
Malignant, neoplastic cell populations are characterized by their autonomous growth, invasiveness and metastatic activity. These features, like normal cellular activities, are all dependant on the interaction between the cells and their microenvironment. The cell membrane therefore constitutes a crucial biological structure in neoplastic cell behaviour.
KeywordsAthymic Nude Mouse Carbohydrate Epitope Metastatic Activity Autonomous Growth Squamous Lung Carcinoma
J.R. Gabin, P. Gordon, J. Ruth, J.A. Archer and D.N. Buell, Characteristics of the human lymphocytes insulin receptor, J. Biol. Chem.
248:2202 (1973).Google Scholar
S. Jacobs and P. Cuatrecasas, Insulin receptor structure and function, Endocrine Rev. 2:251 (1981).CrossRefGoogle Scholar
H.O. McDevitt, Current concepts in immunology: Regulation of the immune response by the major histocombatibility system, N. Engl. J. Med.
303:1514 (1980).CrossRefGoogle Scholar
L. Hood, M. Steinmetz and B. Mulissen, Genes of the major histocompatibility complex of the mouse, Ann. Rev. Immunol.
1:529 (1983).CrossRefGoogle Scholar
J. Lotem and L. Sachs, Regulation of normal differentiation in mouse and human myeloid leukemia cells by phorbol ester and the mechanism of tumor promotion, Carcinog. Compr. Surv.
7:385 (1982).Google Scholar
R.W. Schroff, K.A. Foon, R.J. Billing and J.L. Fahey, Immunologie classification by lymphocytic leukemias based on monoclonal antibody-defined cell surface antigens, Blood
59:207 (1982).Google Scholar
A.J. McMichal and J.W. Fabre (eds), “Monoclonal antibodies in clinical medicine.” Academic Press, London (1982).Google Scholar
M.S. Mitchell and H.F. Oettgen, Hybridomas in cancer diagnosis and treatment, Prog. Cancer Res. Ther.
21:1 (1982).Google Scholar
R.J. Cohen and H.N. Eisen, Hypothesis: Interaction of macromolecules on cell membranes and restriction of T-cell specificity by products of the major histocompatibility comples, Cell Immunol.
32:1 (1977).CrossRefGoogle Scholar
M. Simonsen and L. Olsson, Possible roles of compound receptors in the immune system, Ann. Immunol.
134D:85 (1983).Google Scholar
M. Simonsen, C. Skjødt and M. Crone, Compound receptors in the cell membrane: Ruminations from the borderland of immunology and physiology, Prog. Allergy
36:151 (1985)Google Scholar
L. Olsson, Human monoclonal antibodies in experimental cancer research, J. Natl. Cancer Inst.
, in press.Google Scholar
L. Old, Cancer immunology: The search for specificity, Cancer Res.
41:361 (1981).Google Scholar
S. Ohno, The original function of MHC antigen as the general plasma membrane anchorage site of organogenesis-directing proteins. Immunol. Rev.
, 33:59 (1977).CrossRefGoogle Scholar
V. Ginsburg, P. Fredman and J. Magnani, Cancer associated carbohydrated antigens detected by monoclonal antibodies, Contrib. Oncol.
19:51 (1984).Google Scholar
S. Hakamori and R. Kannagi, Glycosphingolipids as tumor-associated and differentiation markers, J. Natl. Cancer Inst.
71:231 (1983).Google Scholar
T. Feizi, Demonstration and glycolipids are onco-developmental antigens, Nature
314:53 (1985).CrossRefGoogle Scholar
P.C. Nowell, The clonal evolution to tumor cell populations, Science
194:23 (1976).CrossRefGoogle Scholar
G. Poste and I.J. Fidler, The pathogenesis of cancer metastasis, Nature
283:139 (1980).CrossRefGoogle Scholar
G.H. Heppner, Tumor heterogeneity, Cancer Res.
44:2259 (1984).Google Scholar
L. Olsson, Phenotypic diversity in leukemia cell population, Cancer Metastasis Rev.
2:153 (1983).CrossRefGoogle Scholar
A.D. Riggs and P.A. Jones, 5-methylcytosine, gene regulation and cancer, Adv. Cancer Res.
40:1 (1983).CrossRefGoogle Scholar
P.A. Jones, Altering gene expression with 5-azacytidine, Cell
40:485 (1985).CrossRefGoogle Scholar
L. Olsson, C. Due and M. Diamant, Treatment of human cell lines with non-mutagenic, non-toxic doses of 5-azacytidine may result in profound alterations in clonogenicity and growth rate, J. Cell. Biol.
100:108 (1985).CrossRefGoogle Scholar
L. Ossowski and E. Reich, Changes in malignant phenotype of a human carcinoma conditioned by growth environment, Cell
33:323 (1983).CrossRefGoogle Scholar
C. Honsik, M. Diamant and L. Olsson, Generation of stable cellular phenotypes in a human malignant cell line conditioned by alterations in the cellular microenvironment, Submitted.Google Scholar
L. Chatenaud and J.F. Bach, Antigenic modulation — a major mechanism of antibody action, Immunol. Today
5:20 (1984).Google Scholar
M.D. Waterfield, G.T. Scarce and N. Whittle, Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of Simian sarcoma virus, Nature
304:35 (1983).CrossRefGoogle Scholar
R.F. Doolittle, M.W. Hunkapilar and L. Hood, Simian sarcoma virus onc-gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor, Science
221:275 (1983).CrossRefGoogle Scholar
T. Hunter, Oncogenes and proto-oncogenes: How do they differ? J. Natl. Cancer Inst.
73:773 (1984).Google Scholar
T. Burgess, Growth factors and oncogenes, Immunol. Today
6:107 (1985).CrossRefGoogle Scholar
A. Ullrich, L. Cousseus and J.S. Hayflink, Human epidermal growth factor receptor. DNA sequence and oberrant expression of the amplified gene in A431 epidernoid carcinoma cells, Nature
309:18 (1984).CrossRefGoogle Scholar
L. Olsson and J. Forchhammer, Induction of the metastatic phenotype in a mouse tumor model by 5-azacytidine and characterization of an antigen associated with metastatic activity, Proc. Natl. Acad. Sci USA
81:7897 (1984).CrossRefGoogle Scholar
I.R. Hart, Molecular basis of tumour spreads, Nature
315:274 (1985).CrossRefGoogle Scholar
R.A. Miller, D.G. Maloney, R. Warnke and R. Levy, Treatment of B-cell lymphoma with monoclonal anti-idiotype antibody, N. Engl. J. Med.
306:517 (1982).CrossRefGoogle Scholar
R. Levy and R.A. Miller, Biological and clinical implications of lymphocyte hybridomas: Tumor therapy with monoclonal antibodies, Ann. Rev. Med.
34:107 (1983).CrossRefGoogle Scholar
H. Koprowski, D. Herlyn and M. Lubeck, Human anti-idiotype antibodies in cancer patients: Is the modulation of the immune response beneficial for the patient?, Proc. Natl. Acad. Sci. USA
81:216 (1984).CrossRefGoogle Scholar
G.T. Nepom, U.T. Nelson and S.L. Holbeck, Induction of immunity to a human tumor marker by in vivo administration of anti-idiotypic antibodies in mice, Proc. Natl. Acad. Sci USA
81:2864 (1984).CrossRefGoogle Scholar
L. Olsson, H.R. Sørensen and O. Behnke, Intratumoral phenotypic diversity of cloned human lung tumor cell lines and consequences for analysis with monoclonal antibodies, Cancer
54:1757 (1984).CrossRefGoogle Scholar
L Olsson, O. Behnke and H.R. Sørensen, Modulatory effects of 5-azacytidine, phorbol ester, and retinoid acid on the malignant phenotype of human lung cancer cells, Int. J. Cancer
35:189 (1985).CrossRefGoogle Scholar
D. Pettijohn, C. Due and E. Rønne, Specific glycoproteins released by human squamous lung carcinoma cells: Characterization and diagnostic applications, J. Natl. Cancer Inst.
, in press.Google Scholar
© Plenum Press, New York 1986